CIK 0000818033
- Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 942875566
- Phone
- +1 858-251-4400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-02-17 | PRENTKI RONALD J President & CEO | Grant or award · Incentive Stock Option (right to buy) | +217,668 | 217,668 | ||
| 2010-02-17 | PRENTKI RONALD J President & CEO | Grant or award · Non-Qualified Stock Option (right to buy) | +32,332 | 32,332 | ||
| 2010-02-17 | Whelan John CFO | Grant or award · Incentive Stock Option (right to buy) | +93,177 | 93,177 | ||
| 2010-02-17 | Whelan John CFO | Grant or award · Non-Qualified Stock Option (right to buy) | +56,823 | 56,823 | ||
| 2010-02-17 | BARR JOHN Vice President of R&D | Grant or award · Incentive Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2010-02-17 | ROSENBLATT TOBY Director | Grant or award | +14,042 | 114,343 | ||
| 2010-02-17 | GODDARD PAUL Director | Grant or award | +14,042 | 118,792 | ||
| 2010-02-17 | ZERBE ROBERT L MD Director | Grant or award | +14,042 | 106,181 | ||
| 2010-02-17 | TURNBULL GREG Director | Grant or award | +14,042 | 149,201 | ||
| 2009-10-19 | TANG KEVIN C Director | Purchase | +2,443,181 | $0.88 | $2.1M | 10,436,506 |
| 2009-10-19 | TANG KEVIN C Director | Purchase · Purchase Rights (right to buy) | +1,586,481 | $0.13 | $198K | 1,586,481 |
| 2009-10-19 | TANG KEVIN C Director | Purchase · Warrants (right to buy) | +1,221,590 | $0.13 | $153K | 1,221,590 |
| 2009-07-08 | PRENTKI RONALD J President & CEO | Grant or award | +63,095 | 63,095 | ||
| 2009-07-08 | PRENTKI RONALD J President & CEO | Returned to the company | −22,556 | $0.90 | $20K | 40,539 |
| 2009-05-27 | ZERBE ROBERT L MD Director | Grant or award | +70,000 | 92,139 | ||
| 2009-05-27 | GODDARD PAUL Director | Grant or award | +70,000 | 104,750 | ||
| 2009-05-27 | TURNBULL GREG Director | Grant or award | +70,000 | 135,159 | ||
| 2009-05-27 | ROSENBLATT TOBY Director | Grant or award | +70,000 | 100,301 | ||
| 2009-02-23 | Whelan John CFO | Grant or award · Incentive Stock Option (right to buy) | +350,000 | 350,000 | ||
| 2009-01-16 | BARR JOHN Vice President of R&D | Grant or award · Non-Qualified Stock Option (right to buy) | +160,000 | 160,000 |
Page 43 of 45 · 881 trades